A Study to Evaluate the Safety and Effectiveness of Different Doses of Chrysalin in Adults Who Have a Broken Wrist

PHASE2TerminatedINTERVENTIONAL
Enrollment

274

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Radius Fracture
Interventions
DRUG

Chrysalin

Patients were treated with a single percutaneous injection of Chrysalin 3 micrograms at the fracture site at the time of surgery.

DRUG

Chrysalin

Patients were treated with a single percutaneous administration of Chrysalin 1 microgram at the fracture site at the time of surgery.

DRUG

Chrysalin

Patients were treated with a single percutaneous administration of Chrysalin 10 micrograms at the fracture site at the time of surgery.

DRUG

Chrysalin

Patients were treated with a single percutaneous administration of Chrysalin 30 micrograms at the fracture site at the time of surgery.

DRUG

Placebo

Patients were treated with a single percutaneous administration of placebo at the fracture site at the time of surgery.

Trial Locations (1)

85281

OrthoLogic, Tempe

Sponsors
All Listed Sponsors
lead

Capstone Therapeutics

INDUSTRY